Copper Storage Disease in Dogs: Welfare Management of a Hereditary Liver Condition

Copper storage hepatopathy is a hereditary liver disease causing toxic copper accumulation in specific dog breeds. Early detection and dietary management can prevent progressive liver damage and the suffering associated with hepatic failure.

Key Facts

Copper storage hepatopathy involves abnormal accumulation of copper in hepatocytes, causing oxidative damage, inflammation, and progressive liver disease.
Bedlington Terriers carry an autosomal recessive mutation in COMMD1 causing severe copper accumulation; Labrador Retrievers, Dalmatians, and Dobermans are also predisposed.
Clinical signs range from asymptomatic (incidental discovery on liver biopsy) to acute haemolytic crisis, chronic hepatitis, cirrhosis, and liver failure.
Diagnosis requires liver biopsy for copper quantification; serum copper and caeruloplasmin levels are unreliable diagnostic tests.
Dietary management with low-copper diets (avoiding organ meats, shellfish) and zinc supplementation (which blocks intestinal copper absorption) is the primary intervention for mild to moderate disease.
Chelation therapy with D-penicillamine or trientine mobilises hepatic copper for urinary excretion; it is used in moderate to severe cases.
DNA testing is available for the Bedlington Terrier COMMD1 mutation; clear, carrier, and affected dogs can be identified to guide breeding decisions.
Labrador Retriever copper-associated hepatopathy has a complex polygenic inheritance; genetic testing is less informative than for Bedlingtons.

Welfare Considerations

Dogs with copper storage hepatopathy experience a spectrum of welfare harms depending on disease severity. Mild accumulation causes no apparent suffering but carries the risk of future liver disease. Chronic hepatitis causes gradual weight loss, lethargy, and reduced quality of life that may be attributed to ageing. Acute haemolytic crisis — when massive copper release from damaged hepatocytes causes red blood cell destruction — is a life-threatening emergency with associated pain and distress. Cirrhosis and end-stage liver failure cause severe malaise, jaundice, ascites, and hepatic encephalopathy. Proactive screening and management — low-copper diet, zinc supplementation, and regular liver monitoring — can maintain good quality of life for years in affected dogs by preventing progression to severe disease.

What You Can Do

If you own a Bedlington Terrier, request DNA testing for the COMMD1 mutation and liver copper quantification biopsy.
Switch to a low-copper diet if your dog has been diagnosed with copper hepatopathy — avoid organ meats, shellfish, and high-copper commercial diets.
Ask your vet about zinc supplementation to reduce intestinal copper absorption as part of long-term management.
Schedule regular liver monitoring (liver enzymes every 6-12 months) for breeds predisposed to copper storage disease.
Responsible breeders of predisposed breeds should test breeding stock and avoid pairing two carriers of known copper storage mutations.